BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 12119472)

  • 1. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests.
    Sirolli V; Ballone E; Garofalo D; Merciaro G; Settefrati N; Di Mascio R; Di Gregorio P; Bonomini M
    Nephron; 2002 Jul; 91(3):424-30. PubMed ID: 12119472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
    van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
    Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Misso NL; Stewart GA; Thompson PJ
    Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
    Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY
    Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of platelet activation markers after ischemic stroke.
    Marquardt L; Ruf A; Mansmann U; Winter R; Schuler M; Buggle F; Mayer H; Grau AJ
    Stroke; 2002 Nov; 33(11):2570-4. PubMed ID: 12411644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
    Choudhury A; Chung I; Blann AD; Lip GY
    J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy.
    Janes SL; Goodall AH
    Clin Sci (Lond); 1994 Jun; 86(6):731-9. PubMed ID: 8062509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
    Chung I; Choudhury A; Patel J; Lip GY
    Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.
    Kamath S; Blann AD; Caine GJ; Gurney D; Chin BS; Lip GY
    Stroke; 2002 May; 33(5):1237-42. PubMed ID: 11988597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of platelet activation].
    Matsuno K
    Rinsho Byori; 1995 May; 43(5):432-7. PubMed ID: 7540228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L.
    Neubauer H; Petrak F; Zahn D; Pepinghege F; Hägele AK; Pirkl PA; Uhl I; Juckel G; Mügge A; Herpertz S
    J Psychiatr Res; 2013 Jul; 47(7):865-71. PubMed ID: 23583028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble P-selectin is released from activated platelets in vivo during hemodialysis.
    Kawabata K; Nagake Y; Shikata K; Fukuda S; Nakazono H; Takahashi M; Ichikawa H; Makino H
    Nephron; 1998; 78(2):148-55. PubMed ID: 9496730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke.
    Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Wang HC; Lee TH; Lu CH
    Thromb Res; 2009 Jun; 124(2):213-8. PubMed ID: 19233449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of membrane glycoproteins in platelet interaction with oxidized low-density lipoprotein.
    Takahashi Y; Fuda H; Yanai H; Akita H; Shuping H; Chiba H; Matsuno K
    Semin Thromb Hemost; 1998; 24(3):251-3. PubMed ID: 9701456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets.
    Chronos NA; Wilson DJ; Janes SL; Hutton RA; Buller NP; Goodall AH
    Clin Sci (Lond); 1994 Nov; 87(5):575-80. PubMed ID: 7533066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disappearance of glycoprotein Ib from the platelet surface in pericardial blood during cardiopulmonary bypass.
    Maquelin KN; Berckmans RJ; Nieuwland R; Schaap MC; ten Have K; Eijsman L; Sturk A
    J Thorac Cardiovasc Surg; 1998 May; 115(5):1160-5. PubMed ID: 9605086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major.
    Ruf A; Pick M; Deutsch V; Patscheke H; Goldfarb A; Rachmilewitz EA; Guillin MC; Eldor A
    Br J Haematol; 1997 Jul; 98(1):51-6. PubMed ID: 9233563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in platelet activation associated with left ventricular assist system placement.
    Matsubayashi H; Fastenau DR; McIntyre JA
    J Heart Lung Transplant; 2000 May; 19(5):462-8. PubMed ID: 10808153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADP causes partial degranulation of platelets in the absence of aggregation.
    Janes SL; Wilson DJ; Cox AD; Chronos NA; Goodall AH
    Br J Haematol; 1994 Mar; 86(3):568-73. PubMed ID: 7519037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.